Brighton Jones’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Buy
4,165
+17
+0.4% +$6.97K 0.03% 343
2026
Q2
$1.62M Sell
4,148
-289
-7% -$122K 0.03% 353
2026
Q1
$2.1M Buy
+4,437
New +$2.23M 0.05% 259
2025
Q4
– Sell
-3,934
Closed -$1.68M – 427
2025
Q3
$1.68M Buy
3,934
+298
+8% +$116K 0.04% 257
2025
Q2
$1.39M Buy
3,636
+178
+5% +$64.1K 0.04% 249
2025
Q1
$1.19M Buy
3,458
+56
+2% +$18K 0.04% 233
2024
Q4
$1.02M Buy
+3,402
New +$1.19M 0.03% 259

Other funds holding HCA

Brighton Jones's HCA Position: Q3 2026 in Review

Brighton Jones increased its HCA Healthcare (HCA) stake by 0.41% in Q3 2026, buying an estimated $6.97K and bringing the position to 4,165 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #343.

Brighton Jones first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.1M in Q1 2026. 1,138 funds tracked by Wall St. Rank hold HCA as of Q3 2026.

  • Brighton Jones held 4,165 shares of HCA Healthcare worth $1.78M as of Q3 2026.
  • Brighton Jones bought 17 HCA Healthcare shares in Q3 2026, an estimated $6.97K.
  • HCA Healthcare made up 0.03% of Brighton Jones's portfolio in Q3 2026, its #343 holding.
  • Brighton Jones first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Brighton Jones's HCA Healthcare position peaked at $2.1M in Q1 2026.
  • 1,138 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.